Researchers Developed New Peptide Bicyclization Method
The PReP-Bicyc approach creates bicyclic ligands to target programmed cell death protein 1 under mild conditions.
Updated on Oct. 3, 2026 in Chemistry
Scientists have introduced a new method called PReP-Bicyc that uses 4,6-dichloropyrimidine-2-carbonitrile to develop peptide bicycles. This approach preserves phage viability while successfully identifying bicyclic ligands that target PD-1.
Why it matters
Peptide bicycles offer superior conformational constraint compared to linear alternatives, yet they have historically been difficult to generate in phage-displayed libraries. This new process facilitates their creation through proximity-driven reactions.
The PReP-Bicyc method achieves bicyclization through nitrile-mediated thiazoline formation and proximity-driven intramolecular thiol arylation. It utilizes a modified CXCXC library to screen for ligands with a binding affinity of approximately 400 nM.
The details
The technique utilizes 4,6-DCCPm to react with an N-terminal cysteine, enabling the formation of complex structures without damaging the phage display. These ligands have demonstrated the ability to selectively label PD-1-expressing cells and effectively inhibit the PD-1/PD-L1 interaction.
Timeline
The research detailing the PReP-Bicyc approach was published on October 3, 2026.
The Big Picture
This development represents a significant evolution in phage display technology, which is the foundational framework for this research. By bridging the gap between library screening and structural constraint, it unlocks the potential to create high-affinity binders for previously difficult protein targets.
This breakthrough provides a new tool for medicinal chemists to develop more potent therapeutic agents against protein interactions involved in diseases like cancer. If successfully commercialized, this methodology could lead to the faster discovery of targeted, highly selective drugs with fewer side effects.
The takeaway
The PReP-Bicyc method demonstrates that complex, highly constrained peptides can be engineered under mild conditions. This discovery confirms that proximity-driven chemistry is a viable pathway for improving the binding affinity of therapeutic peptides.
Further reading
Explore the latest developments in molecular science at the Chemistry section.
More information
Read the complete peer-reviewed research article for further technical details.
